Avid Bioservices Inc (CDMO)

[peregr]

"The facts are plain and simple".
Yes, the prior group at PPHM was not able to monetize the IP and wasted a lot of shareholder money.

Oncologie entered into a partnership agreement, assuming all costs and risks, with CDMO. This was based upon their assessment of the biomarker subset data.

I guess we'll find out whose assessment is correct. I'm thinking a Harvard Med School professor and top oncology researcher has the inside track.